Home > Financial Ratios > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Core EBITDA Growth

    Back to All Ratios
MOREPEN LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MOREPEN LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 11.49101.47-45.3620.0567.42

What is the latest Core EBITDA Growth ratio of MOREPEN LABORATORIES ?

The latest Core EBITDA Growth ratio of MOREPEN LABORATORIES is 11.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202511.49
Mar2024101.47
Mar2023-45.36
Mar202220.05
Mar202167.42

How is Core EBITDA Growth of MOREPEN LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 11.49
-88.68
Mar2024 101.47
Positive
Mar2023 -45.36
Negative
Mar2022 20.05
-70.26
Mar2021 67.42 -

Other Financial Ratios of MOREPEN LABORATORIES


Compare Core EBITDA Growth ratio of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹2,090.6 Cr -2.6% -3.8% -18.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

-2.6%

-3.8%

-18.9%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses